NEW YORK (GenomeWeb) — Life science research tool firm Zephyrus Biosciences said today that it has secured approximately $1.9 million in funding to develop and commercialize its single-cell Western blotting (scWestern) system.
The $1.5 million series seed funding was led by Bay Area investor group Life Sciences Angels, and also included Mission Bay Capital, The Angel Forum, the Stanford StartX Fund, and several individual investors with deep life sciences experience, Zephyrus said.